# Subarachnoid Hemorrhage Recovery And Galantamine

> **NCT02872857** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 60 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Placebo
- **DRUG:** 8mg galantamine twice daily
- **DRUG:** 12mg galantamine twice daily

## Key facts

- **NCT ID:** NCT02872857
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-07-20
- **Final completion:** 2019-07-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872857, "Subarachnoid Hemorrhage Recovery And Galantamine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02872857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*